Perceptive Advisors LLC purchased a new stake in shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 200,000 shares of the medical equipment provider’s stock, valued at approximately $24,134,000. Perceptive Advisors LLC owned about 0.10% of Zimmer Biomet as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of ZBH. Empire Life Investments Inc. raised its holdings in Zimmer Biomet by 9.3% in the 4th quarter. Empire Life Investments Inc. now owns 423,163 shares of the medical equipment provider’s stock worth $51,063,000 after purchasing an additional 35,972 shares in the last quarter. Two Sigma Advisers LP raised its holdings in Zimmer Biomet by 823.1% in the 4th quarter. Two Sigma Advisers LP now owns 739,522 shares of the medical equipment provider’s stock worth $89,238,000 after purchasing an additional 659,412 shares in the last quarter. Jones Financial Companies Lllp bought a new position in Zimmer Biomet in the 4th quarter worth $323,000. Teachers Insurance & Annuity Association of America bought a new position in Zimmer Biomet in the 4th quarter worth $626,000. Finally, HPM Partners LLC raised its holdings in Zimmer Biomet by 4.2% in the 4th quarter. HPM Partners LLC now owns 11,958 shares of the medical equipment provider’s stock worth $1,443,000 after purchasing an additional 484 shares in the last quarter. Institutional investors own 86.64% of the company’s stock.
Shares of Zimmer Biomet Holdings Inc (NYSE ZBH) opened at $120.86 on Monday. Zimmer Biomet Holdings Inc has a 1 year low of $108.03 and a 1 year high of $133.49. The company has a market cap of $24,552.33, a PE ratio of 15.05, a P/E/G ratio of 2.13 and a beta of 1.13. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.81 and a current ratio of 1.50.
Several research analysts have commented on ZBH shares. Deutsche Bank upgraded shares of Zimmer Biomet from a “hold” rating to a “buy” rating and set a $128.00 price objective for the company in a report on Tuesday, November 14th. Zacks Investment Research lowered shares of Zimmer Biomet from a “hold” rating to a “strong sell” rating in a report on Monday, November 20th. Canaccord Genuity restated a “hold” rating and issued a $125.00 price objective on shares of Zimmer Biomet in a report on Tuesday, December 19th. Goldman Sachs Group raised shares of Zimmer Biomet from a “sell” rating to a “neutral” rating and set a $125.00 target price on the stock in a research report on Tuesday, December 19th. Finally, Oppenheimer reaffirmed a “buy” rating on shares of Zimmer Biomet in a research report on Tuesday, December 19th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $141.06.
In other news, insider Bryan C. Hanson acquired 25,077 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were bought at an average cost of $119.68 per share, with a total value of $3,001,215.36. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Chad F. Phipps sold 20,826 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $115.95, for a total transaction of $2,414,774.70. The disclosure for this sale can be found here. Corporate insiders own 1.07% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Perceptive Advisors LLC Purchases Shares of 200,000 Zimmer Biomet Holdings Inc (ZBH)” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at https://www.americanbankingnews.com/2018/03/12/perceptive-advisors-llc-purchases-shares-of-200000-zimmer-biomet-holdings-inc-zbh.html.
Zimmer Biomet Profile
Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.
Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.